Announcement Montreal, May 14, 2025 – CQDM is proud to announce the funding of an innovative artificial intelligence (AI) project aimed at developing targeted therapies for various forms of cancer, alongside companion diagnostic tests designed to enhance patient selection in clinical settings. Valued at nearly $1.8 million, the initiative is led by two fast-growing Quebec…
Announcement Montreal, May 13, 2025 – CQDM and l’Oncopole, pôle cancer du FRQ-santé, are proud to announce the funding of a collaborative research project as part of the Call for collaborative research projects on precision care in oncology. This project aims to evaluate the effectiveness of a radiopharmaceutical anti-cancer therapy, that can both diagnose cancer…
Announcement MONTREAL, May 7, 2025 – CQDM and the Brain Canada Foundation are proud to announce the funding of a research project to identify new chemical compounds with the potential to treat mental health disorders. This project, worth over $1.1 million, is made possible by a $200,820 grant from the Government of Quebec, awarded by…
Announcement MONTREAL, April 30 2025 – CQDM and the CHU Sainte-Justine are proud to announce the creation of the Centre d’expertise sur les maladies rares médiées par le complément (here after the Centre d’expertise), a translational research initiative aiming to revolutionize comprehension, diagnosis and treatment of rare diseases. This project, announced today, boasts a first…
As part of our partnership with Conscience, CQDM is proud to co-host a panel at EFFERVESCENCE 2025, the must-attend life sciences event in North America.🎤 Panel: Building the Future Together – Open Science in Drug DevelopmentThis discussion will bring together Matt Goddeeris (Every Cure), Sébastien Giguère (Valence Discovery), Jason Karamchandani (C-BIG Repository, McGill University), and…
Welcome to Kristin Davis, MSc, our new Project Manager, Scientific Affairs at CQDM! Kristin joined us in, bringing over five years of experience in research funding, both in grant administration and from the recipient’s perspective. She has successfully managed complex, interdisciplinary projects in public health, molecular biology, and psychiatry. With a BSc in Biochemistry from…
This partnership was made possible through a CQDM Connect-Pharma call for proposals, an initiative that gives Canadian companies and researchers the opportunity to directly engage with CQDM’s international pharmaceutical members.CQDM plays a unique role as a facilitator of healthcare innovation, going well beyond financial investment. Thanks to its strong connections with major pharmaceutical players and…
Congratulations to Synucure Therapeutics, which has just completed a $2.8 million financing round, with 50% of the funding coming from the Government of Québec through Investissement Québec as part of the Impulsion PME program.👏CQDM is proud to have supported this project by acting as an advisor and referring entity, helping facilitate access to this crucial…
Announcement Montreal, March 12, 2025 – The CQDM Board of Directors is proud to announce the appointment of Véronique Dugas as the next President and Chief Executive Officer (CEO) of CQDM. She will succeed Diane Gosselin, who, after 17 years of dedicated service to the organization, including 13 years at its helm, will be retiring.…
🚀💊 Are you ready to revolutionize the digital health and artificial intelligence (AI) sectors? Join the Merck Digital Sciences Studio (MDSS) and collaborate with a global leader! 🧬🔍 The MDSS program in partnership with Centech Mtl and CQDM is a six-month program in Montreal that equips startups in the digital health and AI sectors with…